Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

NCT00911807 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Cerebrolysin + donepezil
DRUG: Cerebrolysin + placebo
DRUG: Donepezil + placebo

Sponsor

Ever Neuro Pharma GmbH

Collaborators

[object Object]